Helicobacter pylori seroprevalence in Crohn's disease: Lack of influence by pharmacological treatment

Hepato-Gastroenterology

Volumn 49, Issue 47, 2002, Pages 1296-1297

  Guslandi, Mario ^a   Fanti, L ^a   Testoni, P A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Ciprofloxacin; Crohn's disease; Helicobacter pylori; Metronidazole; Sulphasalazine

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; IMMUNOGLOBULIN G; METRONIDAZOLE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; TIME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COMORBIDITY; CROHN DISEASE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0036376881     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Low prevalence of Helicobacter pylori in inflammatory bowel disease: Association with sulphasalazine
2. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel disease
3. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease
4. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease
5. Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease
6. High frequency of Helicobacter negative gastritis in patients with Crohn's disease
7. Helicobacter pylori-positive gastritis in pediatric patients with chronic inflammatory bowel disease
8. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy
9. Long-term follow-up and serological assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer
10. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease